Skip to main content

The New Iridium Complexes Involving Pyridylpyridine Derivatives for the Saturated Blue Emission

Buy Article:

$105.00 plus tax (Refund Policy)

To obtain a saturated blue phosphorescent material with a good color purity, we have synthesized the new blue emitting iridium complexes with 2,6-difluoro-3-(4-methylpyridin-2-yl)pyridine (4-Me-dfpypy) as a main ligand. We expected that the LUMO energy levels of the complex might increase upon introduction of an electron donating group such as a methyl group to the pyridyl moieties of the ligand, leading to a wide energy gap of the complex to give the saturated blue emission. We have also introduced a variety of the ancillary ligands to the iridium center to compare the effect of the ancillary ligards on the emission of their complexes. The resulting iridium complexes, Ir(4-Me-dfpypy)3, Ir(4-Me-dfpypy)2(acac), Ir(4-Me-dfpypy)2(pic) and Ir(4-Me-dfpypy)2(trzl-CH3) where acac, pic, and trzl-CH3 represent acetylacetonate, picolinate, and 2-(5-methyl-2H-1,2,4-triazol-3-yl) pyridinate, respectively exhibited the blue emission at 451, 447, 440 and 425 nm in CH2Cl2 solution. The organic light emitting device (OLED) employing homoleptic Ir(4-Me-dfpypy)3 as the blue dopant was prepared and their electroluminescence was investigated. Ir(4-Me-dfpypy)3 exhibited the blue emission of CIE coordinates (0.22, 0.32).
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: 2012-01-01

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more